𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Exercise therapy for people with rheumatoid arthritis and osteoarthritis

✍ Scribed by Jyrki A. Kettunen; Urho M. Kujala


Book ID
111265495
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
112 KB
Volume
14
Category
Article
ISSN
0905-7188

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Efficacy of physical conditioning exerci
✍ Marian A. Minor; Richard R. Webel; Donald R. Kay; John E. Hewett; Sharon K. Ande πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 890 KB

A group of 120 patients with rheumatoid arthritis or osteoarthritis volunteered to be subjects for this study of aerobic versus nonaerobic exercise. Patients were stratified by diagnosis and randomized into an exercise program of aerobic walking, aerobic aquatics, or nonaerobic range of motion (cont

Photodynamic therapy for rheumatoid arth
✍ Hendrich, Christian; Siebert, Werner E. πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 2 views

## Background and objective: The only early surgical therapy of rheumatoid arthritis is synovectomy. but even an arthroscopic synovectomy is restricted to more or less big joints. it has been shown recently that for smaller joints a laser synovectomy is possible but more time-consuming than with me

Gene therapy for rheumatoid arthritis
✍ Natacha Bessis; Christelle Doucet; Virginie Cottard; Anne-Marie Douar; HΓΌseyin F πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 180 KB

## Abstract Rheumatoid arthritis (RA) is a severe autoimmune systemic disease. Chronic synovial inflammation results in destruction of the joints. No conventional treatment is efficient in RA. Gene therapy of RA targets mainly the players of inflammation or articular destruction: TNF‐α or IL‐1 bloc

Diet therapy for rheumatoid arthritis
✍ Richard S. Panush; Randy L. Carter; Paul Katz; Badri Kowsari; Selden Longley; Sh πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 783 KB

Although diet therapy for arthritis has received considerable publicity, there is little objective information about its efficacy. We undertook a 10-week, controlled, double-blind, randomized trial of patients with active rheumatoid arthritis (RA). Twenty-six patients completed the study; 11 were on